Shanghai Pharma Research Institute

Shanghai Pharma Research Institute serves as the core research and development engine for Shanghai Pharmaceuticals Holding Co., Ltd., one of China's largest integrated pharmaceutical groups. The institute focuses on the discovery and clinical development of innovative small molecules and biologics, particularly in the fields of oncology, cardiovascular disease, and immunology. It operates specialized platforms for antibody engineering, high-throughput screening, and advanced modalities such as cell and gene therapy. By combining internal research with strategic global partnerships, the institute drives the group's transition from a traditional manufacturer to a leader in high-value innovative medicine. Its robust pipeline includes several late-stage candidates targeting significant unmet needs in the Chinese and global markets.